CurrentRheuma
Get Weekly

Topic · page 16 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 601–640 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Arthritis Rheumatol

    Genetics of Childhood‐Onset Systemic Lupus Erythematosus

    Cohort study

  2. Ann Rheum Dis

    Integrative spatial multiomics analysis reveals regulatory mechanisms of VCAM1+ proximal tubule cells in lupus nephritis

    Mechanistic study

  3. Arthritis Rheumatol

    Pharmacodynamic Effects of Litifilimab in Lupus in a Randomized, Placebo‐Controlled Phase 2 Study: Rapid and Sustained Reductions in Type I Interferon‐Associated Gene Expression and Cytokines

    Secondary analysis

  4. Lancet Rheumatol

    Patient outcomes from implementing a shared decision-making aid for systemic lupus erythematosus: a prospective implementation study

    Cohort study

  5. Lupus

    Obesity is an independent poor prognostic factor in lupus nephritis

    Cohort study

  6. Lupus Sci Med

    TSPO PET/MR in neuropsychiatric lupus: neuroinflammatory metabolic signatures and diagnostic biomarkers

    Cohort study

  7. Lupus Sci Med

    Vitamin D receptor expression level in patients with SLE and its relationship with vitamin D status, disease course and bone mineral density

    Cross-sectional study

  8. J Rheumatol

    Association of Patient Resilience With Patient-Reported Physical and Mental/Emotional Quality of Life in Systemic Lupus Erythematosus

    Cohort study

  9. Rheumatology (Oxford)

    Hydroxychloroquine discontinuation in SLE: a retrospective cohort study with 3-year follow-up

    Cohort study

  10. Lupus Sci Med

    Cortical changes in women with systemic lupus erythematosus with mild cognitive impairment: a voxel-based morphometry and surface-based morphometry study

    Cross-sectional study

  11. Rheumatology (Oxford)

    Elevated pre-eclampsia risk in lupus nephritis and antiphospholipid syndrome: a nationwide Spanish registry analysis

    Cohort study

  12. Ann Rheum Dis

    IL-2 signalling sustains pathogenic age-associated B cell homeostasis in lupus

    Mechanistic study

  13. Lupus

    Prevalence of systemic lupus erythematosus in Peru and its association with environmental and healthcare factors: An ecological study

    Research article

  14. Rheumatology (Oxford)

    Is antimalarial use associated with a reduced risk of LN in patients with SLE? Results from an inception cohort-based study

    Cohort study

  15. Rheumatology (Oxford)

    Sustained cardiovascular risk factor control is associated with reduced metabolic dysfunction-associated steatotic liver disease risk in SLE

    Cross-sectional study

  16. RMD Open

    Distribution of nailfold videocapillaroscopy parameters in systemic lupus erythematosus and their association with disease activity: an international blinded case–control analysis on behalf of the EULAR study group on microcirculation in rheumatic diseases

    Cohort study

  17. Lupus Sci Med

    Immunogenicity, safety and adverse events of sequential vaccination with a 10-valent pneumococcal conjugate vaccine (PCV10) and PPSV23 compared with PPSV23 alone in systemic lupus erythematosus

    Randomized controlled trial

  18. Lupus

    Efficacy and safety of Belimumab, Rituximab and Voclosporin in the treatment of lupus nephritis based on registered clinical trials: A systematic review and network meta-analysis

    Meta-analysis

  19. Rheumatology (Oxford)

    A new characteristic of SLE: subclinical vein involvement–an in-depth biochemical and imaging study

    Cross-sectional study

  20. Lupus Sci Med

    Prevalence and incidence of systemic lupus erythematosus in Thailand based on national health data

    Cohort study

  21. Rheumatology (Oxford)

    Venous thromboembolism in patients with lupus nephritis: frequency and risk factors—a cohort study

    Cohort study

  22. Arthritis Res Ther

    A 6-year prospective study on work participation and the associated factors in Dutch patients with systemic lupus erythematosus (SLE)

    Cohort study

  23. RMD Open

    Accrual of thromboembolic events and antiphospholipid syndrome in new-onset systemic lupus erythematosus: a population-based inception cohort study

    Cohort study

  24. Lupus Sci Med

    Glycosylation of anti-dsDNA IgG correlates with organ involvement in treatment-naïve patients with systemic lupus erythematosus

    Cross-sectional study

  25. Lupus Sci Med

    Enhancing predictions of subclinical cardiac dysfunction in SLE patients through integrative machine learning analysis

    Case-control study

  26. Clin Exp Rheumatol

    Increased expression of TRIM69 in peripheral blood from systemic lupus erythematosus and its clinical significance

    Diagnostic or prognostic study

  27. Lupus

    Right heart failure outcomes in systemic lupus erythematosus: Cardiovascular insights from a nationwide inpatient study

    Cohort study

  28. Lupus

    Epstein-Barr virus infection and its association with systemic lupus erythematosus: Systematic review and meta-analysis

    Meta-analysis

  29. Rheumatology (Oxford)

    Arterial stiffness in different age and cardiovascular risk groups of patients with systemic lupus erythematosus

    Cross-sectional study

  30. Semin Arthritis Rheum

    Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study

    Cohort study

  31. Clin Exp Rheumatol

    Ultrasensitive serum interleukin-8 levels show no association with disease activity or autoantibody profile but relate to cardiovascular comorbidity in systemic lupus erythematosus

    Cross-sectional study

  32. RMD Open

    Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis

    Meta-analysis

  33. Lupus

    Clinical, pathological and immunological features of toxic-epidermal necrolysis like lupus erythematosus: A systematic review and proposal for diagnostic criteria

    Meta-analysis

  34. Ann Rheum Dis

    Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus

    Mechanistic study

  35. Lupus

    Comparison of clinicopathological characteristics and outcomes between patients with late and early-onset systemic lupus erythematosus with lupus nephritis: A North African study

    Cohort study

  36. Lupus

    Expression and significance of TWEAK and CD163 in monocytes of patients with newly diagnosed systemic lupus erythematosus with renal involvement

    Diagnostic or prognostic study

  37. Lupus

    Evaluating the performance of four anti-dsDNA antibody detection methods

    Diagnostic or prognostic study

  38. Ann Rheum Dis

    SLE classification criteria item relationships: implications on SLE as a disease entity

    Cross-sectional study

  39. Lupus Sci Med

    Advancing treat-to-target in SLE: a pilot study using a clinical decision support system

    Research article

  40. Ann Rheum Dis

    Genetic and epigenetic dysregulation of CR1 is associated with catastrophic antiphospholipid syndrome

    Mechanistic study

All 1,848 Briefs in ExploreShowing Briefs 601–640 of 1,848, newest first